Latest receivables for TSVT: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
2seventy bio (TSVT) currently reports a receivables of $0 as of March 2025. That compares with $12M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore 2seventy bio's receivables history and peer comparisons.
2seventy bio's receivables decreased from $12M to $0 — a 100.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
2seventy bio reported $0 in receivables as of March 2025. That compares with $12M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 2seventy bio, and consider following TSVT for alerts when major investors trade the stock.